OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
1.460
-0.030 (-2.01%)
Mar 28, 2024, 11:53 AM EDT - Market open

OKYO Pharma Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019
Cash & Equivalents
4.052.76.890.24
Cash & Cash Equivalents
4.052.76.890.24
Cash Growth
49.79%-60.80%2825.59%-
Receivables
0.590.810.070.26
Other Current Assets
0.560.780.030.07
Total Current Assets
5.24.36.990.57
Property, Plant & Equipment
0.010.010.10.03
Total Long-Term Assets
0.010.010.10.03
Total Assets
5.24.37.090.6
Accounts Payable
5.041.351.670.71
Current Debt
2.2200.030.01
Total Current Liabilities
7.261.351.710.71
Long-Term Debt
000.060.03
Total Long-Term Liabilities
000.060.03
Total Liabilities
7.261.351.770.74
Total Debt
2.2200.10.03
Debt Growth
--211.65%-
Retained Earnings
-125.7-112.43-106-102.43
Comprehensive Income
-11.45-11.01-10.17-10.52
Shareholders' Equity
-2.052.955.32-0.14
Net Cash / Debt
1.832.76.790.2
Net Cash / Debt Growth
-32.23%-60.23%3232.04%-
Working Capital
-2.062.945.28-0.14
Book Value Per Share
-0.070.140.25-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).